Evidence map›Paper›PMID 35806440›Full record

ArticleInternational journal of molecular sciences2022

Bioengineered Silkworm for Producing Cocoons with High Fibroin Content for Regenerated Fibroin Biomaterial-Based Applications.

Mana Yamano, Ryoko Hirose, Ping Ying Lye, Keiko Takaki, Rina Maruta, Mervyn Wing On Liew, Shinichi Sakurai, Hajime Mori, Eiji Kotani

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Targeting the circadian negative regulatorMaterials today. Bio · 2026
    Article
  2. Application of Transgenic Silk Fibroin to Biomaterials.Biotechnology and bioengineering · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Mana YamanoDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Ryoko HiroseDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Ping Ying LyeDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Keiko TakakiDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.ORCID 0000-0002-9525-370X
Rina MarutaDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Mervyn Wing On LiewInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden, Penang 11800, Malaysia.
Shinichi SakuraiDepartment of Biobased Materials Science, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.ORCID 0000-0002-5756-1066
Hajime MoriDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Eiji KotaniDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Kyoto Institute of Technology · JPIndian Institute of Technology Guwahati · INUniversiti Sains Malaysia · MY

Funding

Japan Science and Technology Agency Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-Step)The Dainippon Silk Foundation Teimei Empress's Memorial Grant
6 · The paper itself

Abstract

Silk fibroin exhibits high biocompatibility and biodegradability, making it a versatile biomaterial for medical applications. However, contaminated silkworm-derived substances in remnant sericin from the filature and degumming process can result in undesired immune reactions and silk allergy, limiting the widespread use of fibroin. Here, we established transgenic silkworms with modified middle silk glands, in which sericin expression was repressed by the ectopic expression of cabbage butterfly-derived cytotoxin pierisin-1A, to produce cocoons composed solely of fibroin. Intact, nondegraded fibroin can be prepared from the transgenic cocoons without the need for sericin removal by the filature and degumming steps that cause fibroin degradation. A wide-angle X-ray diffraction analysis revealed low crystallinity in the transgenic cocoons. However, nondegraded fibroin obtained from transgenic cocoons enabled the formation of fibroin sponges with varying densities by using 1-5% (

Indexed as

BombyxFibroinsSericinsAnimalsAnimals, Genetically ModifiedBiocompatible MaterialsSilkBiocompatible MaterialsFibroinsSericinsSilkbiomaterialBombyx moribone regenerationfibroin

Identifiers

PMID35806440
PMCPMC9267247
OpenAlexW4283795328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.